5-Chloro-Thiazole

5‑Chloro‑thiazole is converted to its organozinc derivative by treatment with activated zinc dust (1.5 eq) in anhydrous tetrahydrofuran at 40–50 °C under argon. The exotherm is moderated by a jacket‑cooled glass‑lined reactor equipped with a pitched‑blade turbine agitator running at 250 rpm. Zinc activation utilises 1,2‑dibromoethane (0.05 eq) and chlorotrimethylsilane (0.03 eq); formation of the heteroarylzinc chloride is monitored by GC until complete consumption of the starting thiazole is observed. The resulting solution is transferred via cannula into a second vessel containing Pd₂(dba)₃ (1.0 mol%) and SPhos (2.5 mol%) pre‑dissolved in N,N‑dimethylacetamide. A deoxygenated solution of the aryl iodide coupling partner (1.15 eq) is added, and the Negishi cross‑coupling proceeds at 70 °C for 12 h. After aqueous quench with 1 M HCl and extraction with ethyl acetate, the crude 5‑arylthiazole intermediate is purified by fractional distillation under reduced pressure (0.5 mmHg, overhead temperature 110–115 °C) to a purity of ≥99.5 % (HPLC, area area normalisation, λ 254 nm). This intermediate enters the supply chain for HIV‑1 protease inhibitor scaffolds; manufacturers typically file a Drug Master File compliant with ICH Q7 and ensure residual heavy metals conform to ICH Q3D guidance. Controlled substances precursor handling follows 21 CFR 1309 where applicable. The material is shipped under nitrogen blanketing in HDPE drums conforming to UN 1H2 with tamper‑evident seals. Storage at 2–8 °C is mandated to prevent slow protodezincation background reactivity that generates unfunctionalised thiazole and reduces coupling yield in subsequent batch campaigns.

How Does Suzuki–Miyaura Coupling of 5‑Chloro‑Thiazole Yield Kinase Inhibitor Fragments?

A catalytic manifold employing Pd(OAc)₂ (0.5–1.0 mol%) and XPhos (2.0 mol%) in degassed 1,4‑dioxane / water (4:1 v/v) enables direct installation of (hetero)aryl groups at the C‑5 position. Potassium phosphate tribasic (2.5 eq) is the preferred base; carbonate bases induce a 10–15 °C higher induction period and raise the viscosity of the biphasic mixture beyond the mixing capability of a standard 45° pitched‑blade impeller. The arylboronic acid is charged in 1.3 eq relative to 5‑chloro‑thiazole, and the mixture is heated to 85 °C with a ramp rate not exceeding 1.5 °C/min to avoid uncontrolled nucleation of palladium black. Reaction progress is tracked by TLC (silica, hexane/ethyl acetate 8:2); total cycle time is typically 6–8 h. Work‑up involves filtration through a plug of Celite‑545, phase separation, and crystallisation from isopropanol/water to afford the 5‑arylthiazole fragment in 82–89 % isolated yield with >98 % chromatographic purity. These fragments feed into parallel medicinal chemistry programmes targeting ATP‑competitive kinase inhibition; the narrow molecular weight window (180–320 Da) satisfies Lipinski’s Rule of Five criteria while the heterocyclic chlorine atom present in the starting material is lost during coupling, removing a potential Ames alert. Export of the boronic acid‑adducted intermediate requires a TSCA inventory check (40 CFR 710) and a Safety Data Sheet aligned with GHS Rev. 8. Scale‑up batches are routinely run in 500‑L enamel‑lined reactors with CIP capability, and the drying step employs a double‑cone rotary dryer operating at 50 °C and 20 mbar to reduce residual dioxane below the 380 ppm limit required by the EMA guideline on residual solvents.

Paraformaldehyde (1.1 eq) and anhydrous hydrogen chloride gas are introduced into a cold suspension of 5‑chloro‑thiazole in concentrated hydrochloric acid (37 %) maintained at 0–5 °C in a Hastelloy‑clad reactor. The chloromethylation is run under slight overpressure (0.2 bar) to maintain a positive HCl blanket, preventing atmospheric moisture ingress that would generate a competing hydrolysis pathway to the hydroxymethyl derivative. After 5 h, the clear solution is warmed to 20 °C and stirred for an additional 3 h. The reaction mass is quenched over crushed ice and extracted with dichloromethane; the organic layer is neutralised with 5 % sodium bicarbonate solution to a final pH of 6.8–7.2. Distillation under vacuum (65–70 °C, 10 mmHg) yields 2‑chloro‑5‑chloromethylthiazole in 88 % yield. This alkylating agent is subsequently condensed with aminoacetonitrile hydrochloride (1.0 eq) in acetonitrile using triethylamine (2.1 eq) as acid scavenger at 40 °C to install the N‑cyanomethyl motif. A final acylation with chloroacetyl chloride (1.05 eq) in the presence of potassium carbonate in acetone delivers the ethaboxam‑type active ingredient after crystallisation from ethyl acetate/hexane. The technical material conforms to FAO Specification 406/TC (content ≥97 %, acetone insolubles ≤0.2 %). Because the intermediate 2‑chloro‑5‑chloromethylthiazole is classified as a severe skin sensitiser (GHS07), dedicated closed‑transfer systems with local exhaust ventilation are required, and operator exposure is monitored per EN 689:2018. Wiping samples are analysed for surface contamination by LC‑MS/MS every shift during campaign production.

Grignard Reagent Formation and Phosphine Ligand Synthesis

Magnesium turnings (1.2 eq, ≥99.8 % purity, particle size 0.5–1.0 mm) are activated by stirring under argon at 250 °C for 2 h in a rigorously dried Schlenk tube, then suspended in anhydrous THF containing a single crystal of iodine (0.01 eq). A solution of 5‑chloro‑thiazole in THF (2.0 M) is added dropwise at such a rate that the internal temperature stabilises at 28–32 °C; initiation usually occurs after 5 % of the halide has been introduced. After complete addition, the dark grey mixture is stirred at 30 °C for an additional 4 h. Titration against menthol / 1,10‑phenanthroline in anhydrous THF indicates a typical Grignard concentration of 0.85–0.92 M. The heteroarylmagnesium chloride solution is cannulated onto a solution of a chlorodiarylphosphine (1.0 eq) in THF at ‑20 °C. After 12 h at room temperature, the reaction is quenched with saturated ammonium chloride and the product thiazole‑phosphine is isolated by column chromatography (neutral alumina, hexane/ethyl acetate) to afford an air‑sensitive viscous oil in 78–85 % yield. The phosphine is complexed with [Rh(COD)₂]BF₄ (0.5 eq) to generate a cationic catalyst used in asymmetric hydrogenation of dehydroamino acid derivatives at 5 bar H₂ pressure. Enantiomeric excess values exceed 99 % ee for the (S)‑enantiomer of N‑acetylphenylalanine methyl ester when the reaction is run in methanol at 25 °C with a substrate/catalyst ratio of 1,000:1. The ligand synthesis campaign is covered by a process validation report referencing ICH Q11; analytical release uses ³¹P NMR (δ 12.3 ppm, CDCl₃) and ICP‑OES for residual magnesium (limit <5 ppm).

A strictly anhydrous mixture of 5‑chloro‑thiazole (1.00 eq), 2,5‑bis(trimethylstannyl)thiophene (1.00 eq), and Pd(PPh₃)₄ (0.5 mol%) in anhydrous toluene is charged into a flame‑dried pressure tube under nitrogen atmosphere inside a glovebox maintaining <0.1 ppm O₂ and H₂O. The tube is sealed and heated in a block heater to 110 °C for 48 h with magnetic stirring at 600 rpm. End‑capping is performed by sequential addition of 2‑(tributylstannyl)thiophene (0.1 eq) and 2‑bromothiophene (0.1 eq), each followed by 8 h of heating. The crude copolymer is precipitated into methanol containing 5 % conc. HCl, collected by centrifugation, and purified by Soxhlet extraction with methanol, acetone, and hexane (each for 24 h) to strip residual tin species and low‑molecular‑weight oligomers. The final chloroform fraction delivers a dark‑blue polymer with a number‑average molecular weight of 28 kDa and a dispersity of 2.1 (GPC, polystyrene standards). When blended with PC₇₁BM in 1:1.5 wt/wt ratio and processed from chlorobenzene containing 3 vol% 1,8‑diiodooctane, the photoactive layer exhibits a power conversion efficiency of 15.3 % in an inverted device architecture (ITO/ZnO/active layer/MoO₃/Ag) measured under AM 1.5 G illumination per IEC 60904‑3. For electronic‑grade applications, metal ion specifications are critical and must comply with the limits below; failure to meet the Pd cap leads to triplet‑state quenching that drops open‑circuit voltage by >80 mV.

Monomer and polymer shipments are packed in double‑liner aluminium bottles sealed under argon, certified for semiconductor logistics according to SEMI E49.8‑1104. Outgassing tests at 130 °C for 2 h show total volatile organic compounds below 1.0 µg/g, ensuring compatibility with vacuum thermal evaporation lines. Because the Stille polymerisation is susceptible to catalyst decomposition at temperatures above 115 °C, a thermal runaway scenario in a scaled‑up reactor is managed by a redundant over‑temperature trip set at 118 °C that quenches the heating mantle and activates external cooling with ‑25 °C brine. Shelf life of the dibutyltin‑end‑capped polymer under recommended storage (‑20 °C) is 6 months; beyond this point, a 6‑hour vacuum annealing at 60 °C is required to restore target molecular weight distribution.

When 5‑Chloro‑Thiazole Is N‑Alkylated to Generate Thiazolium‑Salt Precatalysts

A neat mixture of 5‑chloro‑thiazole and an excess of methyl iodide (3.0 eq) in a sealed heavy‑walled glass pressure vessel is heated to 50 °C for 18 h in the absence of light. The resulting crystalline precipitate is filtered under nitrogen, washed with cold diethyl ether, and dried in vacuo at 25 °C to yield 3‑methyl‑5‑chlorothiazolium iodide in 94 % yield. The salt is hygroscopic; pre‑drying at 40 °C and relative humidity <30 % is critical to prevent hydrolysis that liberates methylthiol and reduces the titre of the active carbene precursor. For in situ generation of the free N‑heterocyclic carbene (thiazol‑2‑ylidene), the iodide is suspended in anhydrous THF and treated with potassium tert‑butoxide (1.05 eq) at 0 °C. The deep red solution is immediately used in benzoin condensation: a 0.1 M solution of benzaldehyde in ethanol containing 5 mol% of the freshly prepared carbene solution is stirred at 60 °C for 2 h, delivering benzoin in 87 % isolated yield after recrystallisation from ethanol. The catalyst shows 5‑fold higher turnover frequency compared to the corresponding thiazolium salt lacking the chloro substituent, attributed to the inductive withdrawal that increases the electrophilicity of the carbene‑aldehyde adduct. Process safety testing by differential scanning calorimetry reveals an energetic decomposition onset at 168 °C (ΔH = ‑480 J/g), so batch drying at temperatures above 60 °C is prohibited. The precatalyst is classified under UN 3077 (environmentally hazardous substance) for transport; packaging must conform to ADR/RID P001 and include a vermiculite‑lined outer container. Warehousing at ≤25 °C with active moisture control (<20 % RH) preserves the quaternary salt titre above 98 % for 12 months. Before charging to the reactor, a Karl Fischer titration confirms residual water content below 500 ppm, as water at higher levels depresses the equilibrium carbene concentration and leads to incomplete conversion of the aldehyde substrate.